cancer research article, page-4

re: cancer research article/pogs If they can hold off making a deal of any sort untill after Coramsine gets well into the phase 2 cancer trial , when potency of the compound becomes apparent to all , the return to shareholders will be greatly increased . There is no cancer drug in this country to come close to Coramsine IMHO , and they are very close to being able to prove that , even to the sceptics who refuse to recognise that the phase 1 results were exceptional . Cheers